Blood holds clues to Cancer's return
NCT ID NCT03325036
COMPLETED
Knowledge-focused
Sponsor: National Taiwan University Hospital
Source: ClinicalTrials.gov ↗
Summary
This study aimed to see if certain markers in the blood could help predict whether head and neck cancer would come back after curative radiotherapy. Researchers followed 60 patients who received this treatment at a single hospital. They measured various immune system signals in the blood to see if they were linked to the cancer returning or to patient survival.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
Taipei, Taiwan